Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Donor Specific Antibodies, Other Anti-human Leucocyte Antibodies and Autoantibodies in the Outcome of Liver Retransplantation

NCT03815864 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.

NCT NCT03815864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Donor Specific Antibodies, Other Anti-human Leucocyte Antibodies and Autoantibodies in the Outcome of Liver Retransplantation
Lead sponsor
London Health Sciences Centre
Phase
Observational
Overall status
Unknown status
Start date
January 1, 1977
Completion date
January 1, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-mediated rejection, liver transplant failure